Delivery of therapeutic agents by nanoparticles made of grapefruit-derived lipids
暂无分享,去创建一个
Hong Jiang | Donald Miller | Jun Yan | Hong Jiang | J. Mu | Huang-Ge Zhang | Jun Yan | Baomei Wang | Xiaoyu Xiang | Huang-Ge Zhang | Xiaoying Zhuang | Xiaoyu Xiang | Zhong‐bin Deng | X. Zhuang | Donald R. Miller | Jingyao Mu | Baomei Wang | Qilong Wang | Zhong-Bin Deng | Qi-long Wang
[1] M. Zöller. Tetraspanins: push and pull in suppressing and promoting metastasis , 2009, Nature Reviews Cancer.
[2] Michael S. Spilman,et al. Cryo-electron tomography of porcine reproductive and respiratory syndrome virus: organization of the nucleocapsid. , 2009, The Journal of general virology.
[3] S M Moghimi,et al. Factors controlling nanoparticle pharmacokinetics: an integrated analysis and perspective. , 2012, Annual review of pharmacology and toxicology.
[4] R. Haugland,et al. Coupling of monoclonal antibodies with biotin. , 1995, Methods in molecular biology.
[5] P. Low,et al. Folate-mediated targeting of antineoplastic drugs, imaging agents, and nucleic acids to cancer cells. , 1998, Journal of controlled release : official journal of the Controlled Release Society.
[6] C. Théry,et al. Membrane vesicles as conveyors of immune responses , 2009, Nature Reviews Immunology.
[7] Kinam Park,et al. Analysis on the current status of targeted drug delivery to tumors. , 2012, Journal of controlled release : official journal of the Controlled Release Society.
[8] Jianping Qi,et al. Absorption, disposition and pharmacokinetics of solid lipid nanoparticles. , 2012, Current drug metabolism.
[9] W. Grizzle,et al. Contribution of MyD88 to the tumor exosome-mediated induction of myeloid derived suppressor cells. , 2010, The American journal of pathology.
[10] R. Manavalan,et al. Nanotherapeutics to overcome conventional cancer chemotherapy limitations. , 2011, Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques.
[11] W. Grizzle,et al. Thymus Exosomes-Like Particles Induce Regulatory T Cells1 , 2008, The Journal of Immunology.
[12] Kenneth A. Dawson,et al. Role of cell cycle on the cellular uptake and dilution of nanoparticles in a cell population. , 2011, Nature nanotechnology.
[13] R. Welti,et al. Overexpression of Arabidopsis Acyl-CoA Binding Protein ACBP3 Promotes Starvation-Induced and Age-Dependent Leaf Senescence[W][OA] , 2010, Plant Cell.
[14] Yasuo Yoshioka,et al. Silica and titanium dioxide nanoparticles cause pregnancy complications in mice. , 2011, Nature nanotechnology.
[15] A. Poliakov,et al. Adipose Tissue Exosome-Like Vesicles Mediate Activation of Macrophage-Induced Insulin Resistance , 2009, Diabetes.
[16] Dongmei Sun,et al. Treatment of brain inflammatory diseases by delivering exosome encapsulated anti-inflammatory drugs from the nasal region to the brain. , 2011, Molecular therapy : the journal of the American Society of Gene Therapy.
[17] J. Reddy,et al. Folate-targeted chemotherapy. , 2004, Advanced drug delivery reviews.
[18] R. N. Saha,et al. Nanoparticulate drug delivery systems for cancer chemotherapy , 2010, Molecular membrane biology.
[19] A. Seifalian,et al. Exosomes as nano-theranostic delivery platforms for gene therapy. , 2013, Advanced drug delivery reviews.
[20] Erik C. Dreaden,et al. Size matters: gold nanoparticles in targeted cancer drug delivery. , 2012, Therapeutic delivery.
[21] Samir Mitragotri,et al. Factors that control the circulation time of nanoparticles in blood: challenges, solutions and future prospects. , 2010, Current pharmaceutical design.
[22] Eleonore Fröhlich,et al. The role of nanoparticle size in hemocompatibility. , 2009, Toxicology.
[23] M. Kislalioglu,et al. Nanoparticles in the pharmaceutical industry and the use of supercritical fluid technologies for nanoparticle production. , 2012, Current drug delivery.
[24] G. Robertson,et al. Toxicological considerations when creating nanoparticle-based drugs and drug delivery systems , 2012, Expert opinion on drug metabolism & toxicology.
[25] W. Grizzle,et al. Immature myeloid cells induced by a high‐fat diet contribute to liver inflammation , 2009, Hepatology.
[26] Yang-hsin Shih,et al. The effect of inorganic ions on the aggregation kinetics of lab-made TiO2 nanoparticles in water , 2012 .
[27] S. Rubin,et al. Human intestinal folate transport: cloning, expression, and distribution of complementary RNA. , 1997, Gastroenterology.
[28] E Ingham,et al. Signalling of DNA damage and cytokines across cell barriers exposed to nanoparticles depends on barrier thickness. , 2011, Nature nanotechnology.
[29] M. Wood,et al. Delivery of siRNA to the mouse brain by systemic injection of targeted exosomes , 2011, Nature Biotechnology.
[30] W. Grizzle,et al. Exosomes are endogenous nanoparticles that can deliver biological information between cells. , 2013, Advanced drug delivery reviews.
[31] J. James,et al. Research strategies for safety evaluation of nanomaterials, part IV: risk assessment of nanoparticles. , 2006, Toxicological sciences : an official journal of the Society of Toxicology.
[32] J. Benoit,et al. Passive and active tumour targeting with nanocarriers. , 2011, Current drug discovery technologies.
[33] J. Belisle,et al. Isolation of a distinct Mycobacterium tuberculosis mannose-capped lipoarabinomannan isoform responsible for recognition by CD1b-restricted T cells. , 2012, Glycobiology.
[34] S. W. Kim,et al. Optimization of factors influencing the transfection efficiency of folate-PEG-folate-graft-polyethylenimine. , 2002, Journal of controlled release : official journal of the Controlled Release Society.
[35] W. Xia,et al. Sensitive bioassay for detection of PPARα potentially hazardous ligands with gold nanoparticle probe. , 2011, Journal of hazardous materials.
[36] Dongmei Sun,et al. A novel nanoparticle drug delivery system: the anti-inflammatory activity of curcumin is enhanced when encapsulated in exosomes. , 2010, Molecular therapy : the journal of the American Society of Gene Therapy.
[37] A. Jackman,et al. Exploitation of the folate receptor in the management of cancer and inflammatory disease. , 2008, Vitamins and hormones.
[38] W. Grizzle,et al. TLR2-mediated expansion of MDSCs is dependent on the source of tumor exosomes. , 2010, The American journal of pathology.
[39] T. Tuschl,et al. Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells , 2001, Nature.